Oric Pharmaceuticals, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$143.0 | -$142.9 | -$110.8 | -$91.8 | -$78.9 |
| Net income | -$129.5 | -$127.8 | -$100.7 | -$89.1 | -$78.7 |
| Cash Flow Statement | |||||
| Free cash flow | -$111.7 | -$113.8 | -$86.5 | -$77.2 | -$60.5 |
Shares outstanding 103.7M · Free float 84.9%
Annual filing data through FY ended December 31, 2025; float as of October 4, 2026.